0 items USD 0.00Search
Your search for "Rheumatoid arthritis" gave back 3024 results.
Oxaprozin (Actirin) is a drug used for the treatment of rheumatoid arthritis, rheumatoid arthritis, osteoarthritis, ankylosis, cervical, shoulder and...
颁补迟补濒辞驳:听
MRRPB5
June 2024
Price: USD 2,900.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
颁补迟补濒辞驳:听
MRRPB5
February 2024
Price: USD 2,900.00
The global Humira market size was valued at US$ 16700 million in 2023. With growing demand in downstream market, the Humira is forecast to a...
颁补迟补濒辞驳:听
LPI
January 2024
Price: USD 3,660.00
Humira (adalimumab) is a tumor necrosis factor (TNF) blocker that reduces the effects of a substance in the body that can cause inflammation. Humira...
颁补迟补濒辞驳:听
GIR
September 2024
Price: USD 3,480.00
Oxaprozin (Actirin) is a drug used for the treatment of rheumatoid arthritis, rheumatoid arthritis, osteoarthritis, ankylosis, cervical, shoulder and...
颁补迟补濒辞驳:听
MRRPB5
May 2023
Price: USD 2,900.00
Septic arthritis is a disease caused by a bacterial infection or invasion in the joints leading to inflammation. Symptoms of septic arthritis include...
颁补迟补濒辞驳:听
MRRPB5
February 2023
Price: USD 2,900.00
Global autoimmune disease diagnostics market will reach $10.81 billion by 2031, growing by 8.1% annually over 2021-2031, driven by the growing...
颁补迟补濒辞驳:听
Grace Market Data
January 2022
Price: USD 3,100.00
Aciclofenac is a new, strong antipyretic, analgesic, anti-arthritis drugs, clinically applicable to the treatment of rheumatoid arthritis, rheumatoid...
颁补迟补濒辞驳:听
MRRPB5
June 2024
Price: USD 2,900.00
Arthritis Monoclonal Antibodies are a group of complex and effective biological agents used to treat arthritis and other immune-mediated inflammatory...
颁补迟补濒辞驳:听
MRRPB5
November 2024
Price: USD 3,950.00
According to our latest study, the global Tumor Necrosis Factor Inhibitor Drug market size was valued at USD million in 2023 and is forecast to a...
颁补迟补濒辞驳:听
GIR
November 2024
Price: USD 3,480.00
Enbrel is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF, a soluble inflammatory cytokine) by...
颁补迟补濒辞驳:听
MRRPB5
October 2024
Price: USD 3,950.00
The global Diflunisal market size is predicted to grow from US$ 382 million in 2025 to US$ 523 million in 2031; it is expected to grow at a CAGR of 5...
颁补迟补濒辞驳:听
LPI
February 2025
Price: USD 3,660.00
Aciclofenac is a new, strong antipyretic, analgesic, anti-arthritis drugs, clinically applicable to the treatment of rheumatoid arthritis, rheumatoid...
颁补迟补濒辞驳:听
MRRPB5
May 2023
Price: USD 2,900.00
The global Methotrexate market size is predicted to grow from US$ 546 million in 2025 to US$ 645 million in 2031; it is expected to grow at a CAGR of...
颁补迟补濒辞驳:听
LPI
March 2025
Price: USD 3,660.00
The global Musculoskeletal System Disorder market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030...
颁补迟补濒辞驳:听
GIR
July 2024
Price: USD 3,480.00
听
